Terns, Inc.   Report issue

For profit Phase 1 Phase 2
Founded: Foster City CA United States (2017)

Organization Overview

First Clinical Trial
2020
NCT04328077
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Terns, Inc.

Active Ingredients

Drugs in Phase 2 Trials (2)

tern-101 (2 trials)

tern-501 (1 trial)

Drugs in Phase 1 Trials (2)

tern-201 (1 trial)

tern-701 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatty Liver (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4